Skip to main content
Visualsonic logo
Account
  • Login
Back
  • Products
    • Products
    • Imaging Systems
      • Vevo F2
      • Vevo F2 LAZR-X20
      • Vevo F2 LT
    • Transducers
      • Browse All Transducers
      • Vevo Optical Fibers and Jackets
    • Vevo LAB Analysis Suite
      • About Vevo LAB
      • Vevo CQ
      • Vevo Strain 2.0
      • Vevo Multiplexer
      • LV Analysis
      • Auto LV
      • Update your Vevo LAB Software
    • Imaging Modes Software
      • High-frequency Ultrasound Imaging
        • 4D-Mode
        • B-Mode
        • 3D-Mode
        • M-Mode
        • Anatomical M-Mode
        • Non-linear Contrast Mode
        • Power Doppler Mode
        • Pulsed-Wave Doppler Mode
        • Color Doppler Mode
        • Tissue Doppler Imaging
        • Digital RF-Mode
        • ECG and Respiration Gating
        • EKV
        • Shear Wave Elastography
      • Photoacoustic Imaging
        • Single Wavelength
        • Oxy-hemo
        • Spectro
        • Multi-wavelength
        • PA EKV
      • Acoustics & Engineering
        • VADA
    • Accessories
      • Vevo Imaging Station
      • Vevo Whole Body Imaging
      • Physiology Monitoring
      • Vevo Infusion Pump
      • Vevo PHANTOM
      • Vevo BRAIN
      • eBox
    • Contrast Agents
      • Photoacoustic Contrast Agents
        • About PA Contrast Agents
        • Angiostamp™800
      • Ultrasound Contrast Agents
        • Vevo MicroMarker
  • Applications
    • Applications
    • Preclinical
      • Oncology
      • Cardiology
      • Theranostics
      • Vascular Biology
      • Neurobiology
      • Developmental
      • Biomarker/Molecular Imaging
      • Image-guided Injection
      • Ischemia/Reperfusion
      • Drug Discovery and Development
      • Colorectal
      • Urogenital
      • Kidney
      • Liver
      • Fibrosis
      • Pulmonary
      • Pancreas
      • MSK
  • Resources
    • Resources
    • FAQ
    • Education
      • Learning Hub: Online Tutorials
      • Tips and Tricks
      • JoVE Videos
      • Request Training
      • Vevo University
    • News and Stories
      • Shared Stories
      • Vevo Blog
      • Research Spotlight
      • Case Studies
    • Grants & Fundings
      • Vevo International Student Awards
      • Grant Support
      • List of Grants & Funding
      • Funded Projects
    • Publications Library
    • Image Gallery
    • Recorded Webinars
    • On Demand Videos
  • Events
    • Events
    • Conferences and Society Meetings
    • Upcoming Webinars
    • Upcoming Workshops
  • Support
    • Support
    • Scientific Support
    • Technical Support
    • Vevo Service Plans
    • Request Training
    • FAQ
  • Our Company
    • Our Company
    • About Us
    • News
    • Our Technology
      • Our Technology
      • Ultra High-Frequency Ultrasound
      • Photoacoustics (PA)
      • Imaging Modes
    • Scientific Advisory Board
    • Patents
  • Contact
    • Contact
    • Contact Us
    • Our Global Offices
    • Maps and Directions
    • Distributors
  • Careers
    • Careers
    • Open Positions at VisualSonics
    • External Job Postings

Search

Publication
Background: Few studies examined the effect of long-acting nitrates on renal function in chronic heart failure (CHF). Thus, we aimed to investigate the effect of long-acting nitrate on the expression of adrenoceptors (AR) and angiotensin II receptor (ATR) …
Read more
Publication
Background: The efficiency and quality of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are crucial for regenerative medicine, disease modeling, drug screening, and the study of the development events during cardiac specification. …
Read more
Publication
Salt inducible kinases (SIKs) are key regulators of cellular metabolism and growth, but their role in cardiomyocyte plasticity and heart failure pathogenesis remains unknown. Here, we showed that loss of SIK1 kinase activity protected against adverse …
Read more
Publication
The usage of doxorubicin is hampered by its life-threatening cardiotoxicity in clinical practice. Dexrazoxane is the only cardioprotective medicine approved by the FDA for preventing doxorubicin-induced cardiac toxicity. Nevertheless, the mechanism of …
Read more
Publication
Left ventricular (LV) contraction is characterized by shortening and thickening of longitudinal and circumferential fibres. To date, it is poorly understood how LV deformation is altered in the pathogenesis of streptozotocin (STZ)-induced type 1 diabetes …
Read more
Publication
Pulmonary arterial hypertension (PAH) is a fatal disease, where death is associated with right heart failure and reduced cardiorespiratory reserve. The Sugen 5416, hypoxia and normoxia Fischer rat model mimics human PAH, although the cause(s) of death …
Read more
Publication
Most prostate cancers depend on androgens for growth, and therefore, the mainstay treatment for advanced, recurrent, or metastatic prostate cancer is androgen deprivation therapy (ADT). A prominent side effect in patients receiving ADT is an obese frailty …
Read more
Publication
Designing a multifunctional theranostic nanoplat- form with optional therapeutic strategies is highly desirable to select the most suitable therapeutic manners for the patient’s cancer treatment. Among all shapes of silver materials, a silver nanoprism …
Read more
Publication
Doxorubicin (Dox) is an effective chemotherapeutic for a variety of pediatric malignancies. Unfortunately, Dox administration often results in a cumulative dose-dependent cardiotoxicity that manifests with marked oxidative stress, leading to heart …
Read more
Publication
Matrix metalloproteinases (MMPs) are proteolytic enzymes that break down extracellular matrix (ECM) components and have shown to be highly active in the myocardial infarction (MI) landscape. In addition to breaking down ECM products, MMPs modulate …
Read more

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Current page 90
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • …
  • Next page ››
  • Last page Last »
  • Warranty and Service
  • Product Retirement
  • Security
  • Modern Slavery Act
  • Privacy
  • Terms of Service

Contact

Call us at: 1.866.416.4636 | Europe: +31 20 808 2913


VisualSonics, the VisualSonics logo, Vevo, Vevo MicroMarker and EKV are registered and unregistered trademarks of FUJIFILM Sonosite, Inc. in various jurisdictions. FUJIFILM is a registered trademark of FUJIFILM Corporation in various jurisdictions.

Copyright © 2025 FUJIFILM VisualSonics, Inc. All rights reserved. FUJIFILM VisualSonics, Inc is a subsidiary of FUJIFILM Sonosite, Inc.